Coronary and systemic hemodynamic effects of clevidipine, an ultra‐short‐acting calcium antagonist, for treatment of hypertension after coronary artery surgery

Abstract

Clevidipine rapidly reduced MAP and induced a systemic, pulmonary and coronary vasodilation with no effect on venous capacitance vessels or HR. Clevidipine caused no adverse effects on myocardial lactate metabolism. Clevidipine thus appears suitable to control blood pressure after CABG.